| 1 |
33858315 | Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis, In-Vitro Inhibition, and Molecular Modeling Studies. | 2022 |
1 |
| 2 |
29907572 | Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction. | 2018 Aug 10 |
1 |
| 3 |
26320860 | Identification and Characterization of an Irreversible Inhibitor of CDK2. | 2015 Sep 17 |
1 |
| 4 |
20957523 | Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells. | 2011 Dec |
1 |
| 5 |
19472189 | Effects of SMYD3 overexpression on transformation, serum dependence, and apoptosis sensitivity in NIH3T3 cells. | 2009 Jun |
1 |
| 6 |
19773423 | The transcriptional co-activator PCAF regulates cdk2 activity. | 2009 Nov |
2 |
| 7 |
16191191 | Biochemical characterization of Cdk2-Speedy/Ringo A2. | 2005 Sep 28 |
1 |
| 8 |
15505811 | Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4. | 2004 Dec 3 |
1 |
| 9 |
14506259 | Substrate specificity of CDK2-cyclin A. What is optimal? | 2003 Dec 19 |
3 |
| 10 |
12501191 | Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. | 2002 Dec 31 |
1 |
| 11 |
11418614 | Specific residues within the alpha 2 integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways. | 2001 Aug 24 |
1 |
| 12 |
11427888 | Structure of GSK3beta reveals a primed phosphorylation mechanism. | 2001 Jul |
1 |
| 13 |
11532001 | The role of Thr160 phosphorylation of Cdk2 in substrate recognition. | 2001 Sep |
1 |
| 14 |
10633045 | Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase. | 2000 Jan 13 |
1 |